Menu
Search
|

Menu

Close
X

DaVita Inc DVA.N (New York Stock Exchange)

59.30 USD
+0.50 (+0.85%)
As of Jul 23
Previous Close 58.80
Open 59.09
Volume 642,452
3m Avg Volume 401,903
Today’s High 59.42
Today’s Low 58.50
52 Week High 79.02
52 Week Low 43.40
Shares Outstanding (mil) 166.40
Market Capitalization (mil) 9,784.32
Forward P/E 18.05
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 12 analysts

KEY STATS

Revenue (mm, USD)
FY19
2,743
FY18
11,405
FY17
10,877
FY16
14,745
EPS (USD)
FY19
0.713
FY18
3.560
FY17
4.745
FY16
4.288
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
18.05
34.39
Price to Sales (TTM)
vs sector
0.87
8.16
Price to Book (MRQ)
vs sector
2.52
4.43
Price to Cash Flow (TTM)
vs sector
7.44
24.27
Total Debt to Equity (MRQ)
vs sector
270.01
17.60
LT Debt to Equity (MRQ)
vs sector
149.33
12.56
Return on Investment (TTM)
vs sector
5.17
12.67
Return on Equity (TTM)
vs sector
13.03
17.18

EXECUTIVE LEADERSHIP

Kent Thiry
Executive Chairman of the Board, Since 2019
Salary: $1,300,000.00
Bonus: $3,303,370.00
Javier Rodriguez
Chief Executive Officer, Director, Since 2019
Salary: $900,000.00
Bonus: $1,947,980.00
Joel Ackerman
Chief Financial Officer, Treasurer, Since 2019
Salary: $700,000.00
Bonus: $1,279,900.00
James Hilger
Chief Accounting Officer, Since 2017
Salary: $375,000.00
Bonus: $176,475.00
James Hearty
Chief Compliance Officer, Since 2018
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Healthcare Facilities & Services
Address:

2000 16th St
DENVER   CO   80202-5158

Phone: +1310.5362668

DaVita Inc., formerly DaVita HealthCare Partners Inc., operates one division: DaVita Kidney Care (Kidney Care). The Kidney Care division consists of the Company's United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. The Company's segments include U.S. dialysis and related lab services and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as an end-stage renal disease (ESRD). In addition, as of March 31, 2019, the Company operated or provided administrative services to 243 outpatient dialysis centers located in nine countries outside of the United States.

SPONSORED STORIES